摘要
目的研究复方皂矾丸在化疗骨髓抑制方面的治疗效果。方法从2009年5月~2014年5月间选取112例恶性肿瘤患者应用化疗治疗的患者,将其分为观察组和对照组,其中观察组患者56例在护理中服用复方皂矾丸,对照组56例患者在化疗后护理中服用利血生片。对两组患者的骨髓抑制情况进行调查,判定药物效果。结果观察组白细胞IV抑制14例（25.00%）,对照组25例（50.00%）;观察组血小板IV抑制22例（39.29）,对照组37例（66.07%）;观察组血红蛋白IV抑制6例（10.71%）,对照组15例（26.79%）,两组相较,差异有统计学意义（P〈0.05）。由此可见,在化疗骨髓抑制治疗方面,复方皂矾丸效果显著。结论复方皂矾丸在治疗临床化疗骨髓抑制方面疗效显著,值得大力推广应用。
Objective To study the curative effect of compound Zaofan pills in treatment of myelosuppression caused by chemotherapy. Methods 112 patients with malignant tumors who were received chemotherapy from May 2009 to May 2014 were selected and they were divided into the observation group and the control group. 56 patients in the observation group were received compound Zaofan pills while 56 patients in the control group were receive leucogen tablets in nursing after chemotherapy. Myelosuppression conditions of two groups were investigated to determine the drug effect. Results 14 cases（25.00%） with the inhibition of leukocyte IV were in the observation group and 25 cases（50.00%） with the inhibition of leukocyte IV were in the control group. 22 cases with IV platelet inhibition were in the observation group while 37 cases（66.07%） with IV platelet inhibition were in the control group. In the observation group, there were 6 cases with hemoglobin IV inhibition, accounting for 10.71%. In the control group, there were 15 cases with hemoglobin IV inhibition, accounting for 26.79%. When two groups were compared, the difference was statistically significant（P 〈0.05）. Thus, compound Zaofan pills had marked effect in the treatment of myelosuppression caused by chemotherapy. Conclusion Compound Zaofan pill has marked curative effect in the treatment of myelosuppression caused by chemotherapy, worthy of promoting the application.
出处
《中国医药科学》
2016年第3期88-91,共4页
China Medicine And Pharmacy
关键词
复方皂矾丸
化疗
骨髓抑制
中药
Compound Zaofan pills
Chemotherapy
Myelosuppression
Traditional Chinese medicine
